Cargando…

Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()

INTRODUCTION: Transforming growth factor-beta 1(TGF-β1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-β1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-β1 in fracture h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarahrudi, Kambiz, Thomas, Anita, Mousavi, Mehdi, Kaiser, Georg, Köttstorfer, Julia, Kecht, Mathias, Hajdu, S., Aharinejad, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135818/
https://www.ncbi.nlm.nih.gov/pubmed/21529804
http://dx.doi.org/10.1016/j.injury.2011.03.055
_version_ 1782208145354915840
author Sarahrudi, Kambiz
Thomas, Anita
Mousavi, Mehdi
Kaiser, Georg
Köttstorfer, Julia
Kecht, Mathias
Hajdu, S.
Aharinejad, S.
author_facet Sarahrudi, Kambiz
Thomas, Anita
Mousavi, Mehdi
Kaiser, Georg
Köttstorfer, Julia
Kecht, Mathias
Hajdu, S.
Aharinejad, S.
author_sort Sarahrudi, Kambiz
collection PubMed
description INTRODUCTION: Transforming growth factor-beta 1(TGF-β1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-β1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-β1 in fracture healing. The purpose of this study was to analyse TGF-β1 local and serum concentrations in fracture healing to further contribute to the understanding of molecular regulation of fracture healing. PATIENTS AND METHODS: Serum samples of 113 patients with long bone fractures were collected over a period of 6 months following a standardised time schedule. TGF-β1 serum concentrations were measured using ELISA. Patients were assigned to 2 groups: Group 1 contained 103 patients with physiological healing. Group 2 contained 10 patients with impaired healing. Patients in both groups were matched. One patient of the group 2 had to be excluded because of missing match partner. In addition, fracture haematoma from 11 patients of group 1 was obtained to analyse local TGF-β1 concentrations. 33 volunteers donated serum which served as control. RESULTS: TGF-β1 serum concentrations increased during the early healing period and were significantly higher in patients with physiological healing compared to controls (P = 0.04). Thereafter, it decreased continuously between weeks 2 and 8 and fell again after week 8. TGF-β1 serum concentrations in patients with physiological healing were significantly higher at week 24 compared to controls (P = 0.05). In non-unions, serum concentrations differed significantly from those of controls at week 6 (P = 0.01). No significant difference in between patients with physiological and impaired fracture healing was observed. Fracture haematoma contained significantly higher TGF-β1 concentrations than peripheral serum of the patients (P = 0.017). CONCLUSION: Elevated levels of TGF-β1 in haematoma and in serum after bone fracture especially during the entire healing process indicate its importance for fracture healing.
format Online
Article
Text
id pubmed-3135818
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-31358182011-08-01 Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing() Sarahrudi, Kambiz Thomas, Anita Mousavi, Mehdi Kaiser, Georg Köttstorfer, Julia Kecht, Mathias Hajdu, S. Aharinejad, S. Injury Article INTRODUCTION: Transforming growth factor-beta 1(TGF-β1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-β1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-β1 in fracture healing. The purpose of this study was to analyse TGF-β1 local and serum concentrations in fracture healing to further contribute to the understanding of molecular regulation of fracture healing. PATIENTS AND METHODS: Serum samples of 113 patients with long bone fractures were collected over a period of 6 months following a standardised time schedule. TGF-β1 serum concentrations were measured using ELISA. Patients were assigned to 2 groups: Group 1 contained 103 patients with physiological healing. Group 2 contained 10 patients with impaired healing. Patients in both groups were matched. One patient of the group 2 had to be excluded because of missing match partner. In addition, fracture haematoma from 11 patients of group 1 was obtained to analyse local TGF-β1 concentrations. 33 volunteers donated serum which served as control. RESULTS: TGF-β1 serum concentrations increased during the early healing period and were significantly higher in patients with physiological healing compared to controls (P = 0.04). Thereafter, it decreased continuously between weeks 2 and 8 and fell again after week 8. TGF-β1 serum concentrations in patients with physiological healing were significantly higher at week 24 compared to controls (P = 0.05). In non-unions, serum concentrations differed significantly from those of controls at week 6 (P = 0.01). No significant difference in between patients with physiological and impaired fracture healing was observed. Fracture haematoma contained significantly higher TGF-β1 concentrations than peripheral serum of the patients (P = 0.017). CONCLUSION: Elevated levels of TGF-β1 in haematoma and in serum after bone fracture especially during the entire healing process indicate its importance for fracture healing. Elsevier 2011-08 /pmc/articles/PMC3135818/ /pubmed/21529804 http://dx.doi.org/10.1016/j.injury.2011.03.055 Text en © 2011 Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license
spellingShingle Article
Sarahrudi, Kambiz
Thomas, Anita
Mousavi, Mehdi
Kaiser, Georg
Köttstorfer, Julia
Kecht, Mathias
Hajdu, S.
Aharinejad, S.
Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
title Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
title_full Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
title_fullStr Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
title_full_unstemmed Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
title_short Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing()
title_sort elevated transforming growth factor-beta 1 (tgf-β1) levels in human fracture healing()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135818/
https://www.ncbi.nlm.nih.gov/pubmed/21529804
http://dx.doi.org/10.1016/j.injury.2011.03.055
work_keys_str_mv AT sarahrudikambiz elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT thomasanita elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT mousavimehdi elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT kaisergeorg elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT kottstorferjulia elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT kechtmathias elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT hajdus elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing
AT aharinejads elevatedtransforminggrowthfactorbeta1tgfb1levelsinhumanfracturehealing